Skip to main content

Alcaraz Lopez, Carlos Jorge

Institutions of which they are part

Senior researcher
Rheumatology
Vall Hebron Institut de Recerca
Alcaraz Lopez, Carlos Jorge

Alcaraz Lopez, Carlos Jorge

Alcaraz Lopez, Carlos Jorge

Institutions of which they are part

Senior researcher
Rheumatology
Vall Hebron Institut de Recerca

Related news

The new therapeutic strategy aims at maintaining the efficacy of thalidomide while avoiding its main systemic adverse effects.

The event, held as part of World Lupus Day, incorporated the perspective of people living with the disease to address the challenges associated with lupus.

The global biopharmaceutical company UCB has acquired the data and clinical knowledge business of IMIDomics, a spin-off of the Vall d’Hebron Institute of Research (VHIR).

Related professionals

Nogue Pich, Berta

Nogue Pich, Berta

Research assistant
Shock, Organ Dysfunction and Resuscitation
Read more
Vidal Otero, Jana

Vidal Otero, Jana

Research technician
Basic, Translational and Clinical Pharmacy Research
Read more
Figuera Segarra, Nuria

Figuera Segarra, Nuria

Research assistant
Multidisciplinary Nursing Research Group
Read more
Fadeuilhe Grau, Christian

Fadeuilhe Grau, Christian

Main researcher
Psychiatry, Mental Health and Addictions
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.